Amphastar Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AMPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

55,232

Value ($000)

1,479

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	1,479	0.0%	55,232	12/31/2025
2025 Q3	11/14/2025	1,448	0.0%	54,335	9/30/2025
2025 Q2	8/14/2025	2,150	0.0%	93,652	6/30/2025
2025 Q1	5/19/2025	2,293	0.0%	79,089	3/31/2025
2024 Q4	2/14/2025	3,090	0.0%	83,231	12/31/2024
2024 Q3	11/14/2024	3,710	0.0%	76,445	9/30/2024
2024 Q2	8/14/2024	3,432	0.0%	85,803	6/30/2024
2024 Q1	5/15/2024	1,925	0.0%	43,836	3/31/2024
2023 Q4	2/14/2024	2,801	0.0%	45,292	12/31/2023
2023 Q3	11/13/2023	2,149	0.0%	46,717	9/30/2023
2023 Q2	8/11/2023	1,464	0.0%	39,051	6/30/2023
2023 Q1	5/15/2023	1,464	0.0%	39,051	3/31/2023
2022 Q4	2/14/2023	1,235	0.0%	44,087	12/31/2022
2022 Q3	11/14/2022	1,304	0.0%	46,423	9/30/2022
2022 Q2	8/12/2022	1,666	0.0%	47,885	6/30/2022
2022 Q1	5/16/2022	1,552	0.0%	43,234	3/31/2022
2021 Q4	2/14/2022	792	0.0%	34,016	12/31/2021
2021 Q3	11/15/2021	647	0.0%	34,016	9/30/2021
2021 Q2	8/16/2021	883	0.0%	43,811	6/30/2021
2021 Q1	5/14/2021	753	0.0%	41,087	3/31/2021
2020 Q4	3/1/2021	826	0.0%	41,087	12/31/2020
2020 Q3	11/13/2020	770	0.0%	41,087	9/30/2020
2020 Q2	8/14/2020	843	0.0%	37,547	6/30/2020
2020 Q1	5/15/2020	655	0.0%	44,169	3/31/2020
2019 Q4	2/14/2020	5,667	0.0%	293,799	12/31/2019